0001309653-24-000002.txt : 20240111
0001309653-24-000002.hdr.sgml : 20240111
20240111160248
ACCESSION NUMBER: 0001309653-24-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240109
FILED AS OF DATE: 20240111
DATE AS OF CHANGE: 20240111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: AZAB MOHAMMAD
CENTRAL INDEX KEY: 0001309653
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33650
FILM NUMBER: 24529265
MAIL ADDRESS:
STREET 1: C/O SUPERGEN, INC.
STREET 2: 4140 DUBLIN BLVD., SUITE 200
CITY: DUBLIN
STATE: CA
ZIP: 94568
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LISATA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0000320017
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 222343568
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 110 ALLEN ROAD
STREET 2: SECOND FLOOR
CITY: BASKING RIDGE
STATE: NJ
ZIP: 07920
BUSINESS PHONE: 908-229-2590
MAIL ADDRESS:
STREET 1: 110 ALLEN ROAD
STREET 2: SECOND FLOOR
CITY: BASKING RIDGE
STATE: NJ
ZIP: 07920
FORMER COMPANY:
FORMER CONFORMED NAME: CALADRIUS BIOSCIENCES, INC.
DATE OF NAME CHANGE: 20170808
FORMER COMPANY:
FORMER CONFORMED NAME: Caladrius Biosciences, Inc.
DATE OF NAME CHANGE: 20150608
FORMER COMPANY:
FORMER CONFORMED NAME: NeoStem, Inc.
DATE OF NAME CHANGE: 20060906
4
1
wk-form4_1705006959.xml
FORM 4
X0508
4
2024-01-09
0
0000320017
LISATA THERAPEUTICS, INC.
LSTA
0001309653
AZAB MOHAMMAD
C/O LISATA THERAPEUTICS, INC,
110 ALLEN ROAD, 2ND FLOOR
BASKING RIDGE
NJ
07920
1
0
0
0
0
Common Stock
2024-01-09
4
A
0
19480
0
A
58680
D
Represents 19,480 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 9, 2025.
Includes 32,280 unvested restricted stock units.
James Nisco, Attorney-in-Fact for Mohammad Azab
2024-01-11